Abstract
Enabling formulations are used by the pharmaceutical industry to help improve bioavailability of compounds with low solubility and permeability properties. Suspoemulsions are a combination strategy of using permeation enhancers in a lipid phase, with drug molecules incorporated as a solid nanosuspension in the aqueous phase to maximise oral exposure. Here, a suspoemulsion is created by bead milling a classical drug suspension to reach nano size range and combining with a lipid blend of Labrasol ALF and Capmul MCM. This formulation increased oral bioavailability from 5% to 24%. The exact mechanism of this improvement is hypothesised but would need further work to establish.
Keywords
Nanosuspension, suspoemulsion, enabling formulations, DCS
How to Cite
Matthews, D., Carr, C., Kale, M. & Bloomfield, D., (2023) “Use of a Suspoemulsion to Improve Bioavailability of a DCS Class IV Compound”, British Journal of Pharmacy 8(2). doi: https://doi.org/10.5920/bjpharm.1408
1113
Views
216
Downloads